Ignite Creation Date:
2025-12-25 @ 12:45 AM
Ignite Modification Date:
2025-12-25 @ 10:57 PM
Study NCT ID:
NCT04371367
Status:
COMPLETED
Last Update Posted:
2021-05-27
First Post:
2020-04-29
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Avdoralimab an Anti-C5aR Antibody, in Patients With COVID-19 Severe Pneumonia ( FORCE )
Sponsor:
Assistance Publique Hopitaux De Marseille
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-04-27
Start Date Type:
ACTUAL
Primary Completion Date:
2021-03-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-03-30
Completion Date Type:
ACTUAL
First Submit Date:
2020-04-29
First Submit QC Date:
None
Study First Post Date:
2020-05-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-05-26
Last Update Post Date:
2021-05-27
Last Update Post Date Type:
ACTUAL